AzTrials
AzTrials

Anxiety AcuteCANINE IVNCT04287452

Canine-Assisted ANxiety Reduction IN Emergency Care IV

A study testing Dog Therapy in people with Anxiety Acute and Chronic Pain, run by Indiana University at 1 site in United States.

Withdrawn

Withdrawn. The study stopped before anyone enrolled.

Official record
Search all trials

Trial summary

Prior literature demonstrates that human stress can be reduced with exposure to animals. This study challenges current dogma by introducing a widely available, low cost method of dog therapy to reduce patient and provider stress. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Anxiety Acute, Chronic Pain
What is being tested?
Dog Therapy
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
0 participants
Where
1 siteUnited States
Study dates
1 Mar 2022to 31 Dec 2022
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Patients
  • Age 18-89 years
  • Chronic pain, defined as pain on most days for >6 weeks
  • Triage pain score >6 out of 10
  • OR
  • Age 18-89 years
Show all 12Show fewer
  • Currently experience crisis, including suicidality, or
  • Meet the standard of a provider assessment of "severe stress" defined by their identification that the patient meets a score of greater than six on the FACES stress scale
  • Providers
  • Faculty, residents, advanced practitioners, and nurses who work in the ED and identify themselves as being the nurse or physician of record for the enrolled patients.
  • Therapy Dog Handlers
  • Handler of a certified therapy dog and volunteer of Eskenazi's Therapy Dog Program

Who cannot join

  • Patients
  • Violent behavior
  • Overt intoxication
  • Non-English speaking
  • Any reported prior fear or adverse reaction to dogs
  • Providers
Show all 9Show fewer
  • Any reported prior fear or adverse reaction to dogs
  • Therapy Dog Handlers
  • None

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Eskenazi Health System

    Indianapolis, Indiana, 46202

Other trials in United States

About this study

Official title: Canine-Assisted ANxiety Reduction IN Emergency Care IV (CANINE IV)

Prior literature demonstrates that human stress can be reduced with exposure to animals. This study challenges current dogma by introducing a widely available, low cost method of dog therapy to reduce patient and provider stress. The objectives of this study are to determine if interaction with a certified therapy dog and handler can;

  • decrease reported anxiety levels in emergency department (ED) patients,
  • decrease salivary cortisol in ED patients,
  • decrease total morphine equivalent dosing in the emergency department or at discharge and/or,
  • decrease reported stress levels in emergency department providers caring for participating patients when compared to usual care.
Being tested
Control, Dog Therapy
Medical subject headings
Chronic Pain

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • ControlOther

    Control

  • Dog TherapyOther

    Exposure to certified therapy dogs and their handler.

Study groups in NCT04287452
Study groupRoleWhat they receive
ControlPlacebo comparatorEmergency department patients enrolled in the control arm will receive usual care. Emergency department providers enrolled in the control arm will work their shift as usual.
Receives: Other: Control
InterventionActive comparatorEmergency department patients and providers in the intervention arm will be exposed to and/or interact with a certified therapy dog and handler
Receives: Other: Dog Therapy

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Morphine equivalent narcotic administration in emergency department patients with chronic pain

    Total morphine equivalent narcotic administration while in the emergency department or as a discharge prescription will be recorded for enrolled patients.

    Measured: Date of enrollment until emergency department discharge, up to 72 hours

  2. Change in reported stress levels in ED patients with chronic pain using Wong-Baker FACES Scale (10 = worst)

    Change in self reported stress levels of emergency department patients using a Wong-Baker FACES Scale for anxiety between baseline and T1

    Measured: Baseline and T1 (~45 minutes after baseline)

  3. Change in salivary cortisol in ED patients with chronic pain

    Change in salivary cortisol levels in emergency department patients between baseline and T1

    Measured: Baseline and T1 (~45 minutes after baseline)

  4. Number of narcotic, sedative and/or neuroleptic doses administered in ED patients with emotional crisis

    Number of narcotic, sedative and/or neuroleptic doses administered in ED patients with emotional crisis

    Measured: Date of enrollment until emergency department discharge, up to 72 hours

  5. Change in reported stress levels in ED patients with emotional crisis using Wong-Baker FACES Scale (10 = worst)

    Change in self reported stress levels of emergency department patients using a Wong-Baker FACES Scale for anxiety between baseline and T1

    Measured: Baseline and T1 (~45 minutes after baseline)

  6. Change in salivary cortisol in ED patients with emotional crisis

    Change in salivary cortisol levels in emergency department patients between baseline and T1

    Measured: Baseline and T1 (~45 minutes after baseline)

Secondary outcomes (1)
  1. Change in salivary cortisol levels in emergency department patients

    Change in salivary cortisol levels in emergency department patients between baseline and T1

    Measured: Baseline and T1 (~45 minutes after baseline)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted27 Feb 2020
  2. Study start1 Mar 2022 (estimated)
  3. Primary completion31 Dec 2022 (estimated)
  4. Study completion31 Dec 2022 (estimated)

Why it stopped: The study has been withdrawn due to the pandemic and lack of funding.

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
0 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04287452
Sponsor's protocol ID
001968358
Acronym
CANINE IV
Status last verified
Jul 2023
First submitted
12 Feb 2020
Last updated
20 Jul 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Braun C, Stangler T, Narveson J, Pettingell S. Animal-assisted therapy as a pain relief intervention for children. Complement Ther Clin Pract. 2009 May;15(2):105-9. doi: 10.1016/j.ctcp.2009.02.008. Epub 2009 Mar 3.

    PubMed 19341990
  • Marcus DA, Bernstein CD, Constantin JM, Kunkel FA, Breuer P, Hanlon RB. Impact of animal-assisted therapy for outpatients with fibromyalgia. Pain Med. 2013 Jan;14(1):43-51. doi: 10.1111/j.1526-4637.2012.01522.x. Epub 2012 Nov 21.

    PubMed 23170993
  • Barker SB, Dawson KS. The effects of animal-assisted therapy on anxiety ratings of hospitalized psychiatric patients. Psychiatr Serv. 1998 Jun;49(6):797-801. doi: 10.1176/ps.49.6.797.

    PubMed 9634160
  • Munoz Lasa S, Maximo Bocanegra N, Valero Alcaide R, Atin Arratibel MA, Varela Donoso E, Ferriero G. Animal assisted interventions in neurorehabilitation: a review of the most recent literature. Neurologia. 2015 Jan-Feb;30(1):1-7. doi: 10.1016/j.nrl.2013.01.012. Epub 2013 May 1. English, Spanish.

    PubMed 23642347
  • Havey J, Vlasses F, Vlasses P, Ludwig P, Hackbarth D. The Effect of Animal-Assisted Therapy on Pain Medication Use After Joint Replacement. Anthrozoos 2014; 27: 361-369.

  • Smith DD, Kellar J, Walters EL, Reibling ET, Phan T, Green SM. Does emergency physician empathy reduce thoughts of litigation? A randomised trial. Emerg Med J. 2016 Aug;33(8):548-52. doi: 10.1136/emermed-2015-205312. Epub 2016 Mar 21.

    PubMed 27002161
  • Kelm Z, Womer J, Walter JK, Feudtner C. Interventions to cultivate physician empathy: a systematic review. BMC Med Educ. 2014 Oct 14;14:219. doi: 10.1186/1472-6920-14-219.

    PubMed 25315848

Questions about this trial

What is this clinical trial studying?

A study testing Dog Therapy in people with Anxiety Acute and Chronic Pain, run by Indiana University at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 12 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: withdrawn, as of the sponsor's last update on 20 Jul 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study was withdrawn before enrolling participants, so there are no results.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Morphine equivalent narcotic administration in emergency department patients with chronic pain (time frame: Date of enrollment until emergency department discharge, up to 72 hours). The study lists 6 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04287452, which also lists 7 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 20 Jul 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in